Tech Company Financing Transactions
Protera Funding Round
Sofinnova Ventures and SOSV joined a $5.6 million Series A funding round for Protera. The round was announced on 6/11/2020.
Transaction Overview
Company Name
Announced On
6/11/2020
Transaction Type
Venture Equity
Amount
$5,600,000
Round
Series A
Investors
Sofinnova Ventures (Lead Investor) (Jo�ko Bobanovic)
Proceeds Purpose
The financing is intended to support the commercialization of Protera's protein ingredient portfolio.
Company Information
Company Status
Private & Independent
Industry
Consumer
Mailing Address
176 avenue Charles de Gaulle
Neuilly-sur-Seine, 92522
France
Neuilly-sur-Seine, 92522
France
Phone
Undisclosed
Website
Email Address
Overview
Protera is advancing the science of protein engineering to address some of the most critical problems and opportunities in food, agriculture, the environment and human health. We streamline protein design and development with MADI, our proprietary deep learning algorithm, to predict high value protein products and enzymes with unprecedented speed.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Leonardo Álvarez
Chief Operating Officer
Francia Navarrete
VP - Engineering
Juan Jimenez
Browse more venture capital transactions:
Prev: 6/11/2020: Vendr venture capital transaction
Next: 6/11/2020: Checkmate Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs